Influenza, Human  >>  Relenza (zanamivir)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Relenza (zanamivir) / GSK, Vaxart
NCT01390792: Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

Completed
N/A
622
NA
Zanamivir hydrate
GlaxoSmithKline
Influenza, Human
02/09
05/09
SSMP, NCT01199744: Relenza® Sentinel Site Monitoring Program in Japan

Completed
N/A
1575
NA
zanamivir
GlaxoSmithKline
Influenza, Human
11/09
04/10
NCT01156701: Prophylactic Efficacy of Relenza Against Influenza A and B

Completed
N/A
171705
NA
Receiving a prescription of Relenza for prophylaxis, No prophylaxis with Relenza
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive, Bronchospasm, Influenza, Human, Asthma, Respiratory Disease, Exacerbation of COPD, Bronchitis, Otitis Maedia, Pneumonia, Sinusitis
05/10
05/10
NCT01462487: Safety of Inhaled Zanamivir in Pregnancy

Completed
N/A
1
US
Treatment with zanamivir
GlaxoSmithKline
Influenza, Human
08/12
08/12

Download Options